Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group

O. Schnell, E. Standl, D. Catrinoiu, S. Genovese, N. Lalic, J. Skra, P. Valensi, D. Rahelic, A. Ceriello,

. 2017 ; 16 (1) : 35. [pub] 20170311

Language English Country Great Britain

Document type Congress, Editorial

The 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group was held on the 20th-21st October 2016 in Munich. This second Summit was organized in light of recently published CVOTs on diabetes, with the aim of serving as a reference meeting for discussion on this topic. Along with presentations on the results of the most recently published CVOTs, panel discussions on trial implications for reimbursement and the perspective of cardiologists and/or nephrologists, as well as on CVOTs weaknesses and potentials constituted the heart of the program. Future activities of the D&CVD EASD Study Group in 2017 include an annual meeting in Milano and the 3rd CVOT Summit on Diabetes of the D&CVD EASD Study Group, in Munich ( http://www.dcvd.org ).

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016730
003      
CZ-PrNML
005      
20180517110543.0
007      
ta
008      
180515s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12933-017-0508-8 $2 doi
035    __
$a (PubMed)28284218
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Schnell, Oliver $u Forschergruppe Diabetes e.V., Munich, Ingolstaedter Landstrasse 1, 85764, Neuherberg, Germany. oliver.schnell@lrz.uni-muenchen.de.
245    10
$a Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group / $c O. Schnell, E. Standl, D. Catrinoiu, S. Genovese, N. Lalic, J. Skra, P. Valensi, D. Rahelic, A. Ceriello,
520    9_
$a The 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group was held on the 20th-21st October 2016 in Munich. This second Summit was organized in light of recently published CVOTs on diabetes, with the aim of serving as a reference meeting for discussion on this topic. Along with presentations on the results of the most recently published CVOTs, panel discussions on trial implications for reimbursement and the perspective of cardiologists and/or nephrologists, as well as on CVOTs weaknesses and potentials constituted the heart of the program. Future activities of the D&CVD EASD Study Group in 2017 include an annual meeting in Milano and the 3rd CVOT Summit on Diabetes of the D&CVD EASD Study Group, in Munich ( http://www.dcvd.org ).
650    _2
$a kardiovaskulární nemoci $x ekonomika $x etiologie $x mortalita $x prevence a kontrola $7 D002318
650    _2
$a klinické zkoušky jako téma $7 D002986
650    _2
$a diabetes mellitus 2. typu $x komplikace $x farmakoterapie $x ekonomika $x mortalita $7 D003924
650    _2
$a náklady na léky $7 D016527
650    _2
$a medicína založená na důkazech $7 D019317
650    _2
$a lidé $7 D006801
650    _2
$a hypoglykemika $x škodlivé účinky $x ekonomika $x terapeutické užití $7 D007004
650    _2
$a úhrada zdravotního pojištění $7 D007349
650    _2
$a ochranné faktory $7 D065840
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a výsledek terapie $7 D016896
655    _2
$a kongresy $7 D016423
655    _2
$a úvodníky $7 D016421
700    1_
$a Standl, Eberhard $u Forschergruppe Diabetes e.V., Munich, Ingolstaedter Landstrasse 1, 85764, Neuherberg, Germany.
700    1_
$a Catrinoiu, Doina $u Internal Medicine Department, Clinical County Emergency Hospital Constanta, Tomis Blvd, No. 145, 900591, Constanta, Romania.
700    1_
$a Genovese, Stefano $u Diabetes and Metabolic Disease Unit, IRCCS MultiMedica, Via Milanese 300, 20099, Sesto San Giovanni, MI, Italy.
700    1_
$a Lalic, Nebojsa $u Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Dr Subotica 13, Belgrade, 11000, Serbia.
700    1_
$a Skra, Jan $u 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, U Nemocnice 1, 128 08, Prague 2, Czech Republic.
700    1_
$a Valensi, Paul $u Department of Endocrinology Diabetology Nutrition, CINFO, CRNH-IdF, Jean VERDIER Hospital, Paris 13 University, Avenue du 14 Juillet, 93140, Bondy, France.
700    1_
$a Rahelic, Dario $u Diabetes and Metabolic Disorders, Dubrava University Hospital, Avenija Gojka Šuška 6, 10000, Zagreb, Croatia.
700    1_
$a Ceriello, Antonio $u Diabetes and Metabolic Disease Unit, IRCCS MultiMedica, Via Milanese 300, 20099, Sesto San Giovanni, MI, Italy.
773    0_
$w MED00008211 $t Cardiovascular diabetology $x 1475-2840 $g Roč. 16, č. 1 (2017), s. 35
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28284218 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180517110720 $b ABA008
999    __
$a ok $b bmc $g 1300354 $s 1013570
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 16 $c 1 $d 35 $e 20170311 $i 1475-2840 $m Cardiovascular diabetology $n Cardiovasc Diabetol $x MED00008211
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...